Investment Stage

Focus Areas

About Investor

Kate Bingham is Managing Partner at SV Health Investors and co-leads the firm’s biotech franchise. She focuses on company creation and biotech investing across drug discovery and development companies in the UK, EU, and US, with SV’s biotech franchise centered on transformational new medicines. Her listed investment range is $30K - $3.0M, with a $1.5M sweet spot. She joined SV in 1991, led many of the firm’s biotech investments, chaired the UK Vaccine Taskforce, and serves on the boards of the Francis Crick Institute and ARIA.